23
Mar
Ranbaxy Laboratories Hits Record Profits With Valtrex Sales Surge
Ranbaxy Laboratories Ltd., India’s pharmaceutical giant, records unprecedented quarterly net profit, largely attributed to Valtrex sales and a significant agreement on Flomax. Surpassing losses from last year, their achievement reflects a remarkable turnaround and strategic market positioning.